Omada Health files to go public

The latest stories trending on MedCity News.

Editor's Pick

Top Story Omada Health Files to Go Public: Will It Be Successful? Omada Health filed for an IPO on Friday. It's the second major digital health company to do so this year, following musculoskeletal company Hinge Health in March.  Sponsored The Best Way to Manage Migraines Without Medication Presented by Cefaly For many people, migraines interfere with daily life, work and relationships. Understanding what's behind them — and how to manage them naturally — can be a powerful step toward lasting relief. Learn More INVEST Chicago is Next Week, Get Your Ticket Now! Don't miss your chance to connect with industry leaders, investors, and innovators at Invest 2025, happening next week! 🎯 Why Attend: Hear from top healthcare executives and investors Discover the latest industry trends and innovations Network with influential decision-makers Gain insights to shape your growth strategies Secure your spot today and be part of the conversation shaping the future of healthcare. Reserve Your Ticket

Featured News

Investors Share How Early Stage Healthcare and Life Science Startups Can Make the Most of New Opportunities [Sponsored] In a webinar sponsored by fintech business Mercury, investors from Breyer Capital and MBX Capital shared their startup trend perspectives on AI, valuation, and alternative funding. Barriers and Pathways to Healthtech Adoption in Clinical Practice Healthtech companies have to navigate a maze of complex regulations, prove their financial model, and win over multiple stakeholders. Finding the right balance between patient protection and innovation is crucial. Trump Strategy to Rein In Drug Prices Revives 'Most Favored Nation' Plan of His First Term President Trump's executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what's called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries. Details From Head-to-Head Phase 3 Test Give Fuller Picture of Zepbound's Edge Over Wegovy Eli Lilly reported that in addition to achieving greater reductions in weight, Zepbound-treated patients achieved greater reductions in waist circumference compared to those treated with Novo Nordisk's Wegovy. Full details from the head-to-head Phase 3 test were presented at the European Congress on Obesity meeting. Why Clinician Involvement is Essential to Driving Hospital Innovation The trouble is that our technical colleagues know how to build beautiful products, but most have not worked within the four walls of healthcare, very seldom within the operating room. As a result, they do not know what will work or what is sufficient to drive engagement. What's needed is collaboration. How AI, Analytics, and Collaboration Can Solve Specialty Drug Spending Challenges [Sponsored] Nicole Bulochnik, Abarca Senior Vice President of Drug Value Strategy, explained how AI, analytics, and cross-sector collaboration can transform specialty drug costs. UPMC Enterprises, Redesign Health Launch New Startup for Chronic Pain Patients UPMC Enterprises and Redesign Health launched a new startup named Glimmer Health. The company partners with primary care providers to improve pain management using a personalized, holisitic approach.

Video   Adding Up the Costs of Medicare Advantage Proponents of Medicare Advantage say that these plans are cost effective and help seniors pay less. However, the Medicare Payment Advisory Commission (MedPAC) — which advises Congress on Medicare policies — recently released a report showing that in 2025, CMS will have spent $84 million more on Medicare Advantage enrollees than if those same individuals were enrolled in traditional Medicare. Still, many seniors say that Medicare Advantage plans suit them better because of low premiums and out-of-pocket costs. So how does this all add up? The government is paying more for Medicare Advantage enrollees, yet these same enrollees are paying less — who makes up the difference?

Sponsored The Top Surgical Instruments Needed for Extractions Presented by ProDentUSA Discover what tools are essential for efficient, safe surgical extractions in today's health care landscape, from elevators to forceps and beyond. Learn More

Resources

MedCity FemFwd: Improving the Collection of Maternal Health Data In this episode, we're joined by Maggie McCullough, CEO of PolicyMap. She discusses what's wrong with the way maternal health data is collected at the federal level and ways it can be improved. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe